Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSIW) Assets Average (2022 - 2025)

Historic Assets Average for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $38.9 million.

  • TriSalus Life Sciences' Assets Average rose 2983.24% to $38.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.9 million, marking a year-over-year increase of 2983.24%. This contributed to the annual value of $24.3 million for FY2024, which is 424.1% up from last year.
  • As of Q3 2025, TriSalus Life Sciences' Assets Average stood at $38.9 million, which was up 2983.24% from $35.0 million recorded in Q2 2025.
  • TriSalus Life Sciences' Assets Average's 5-year high stood at $250.9 million during Q3 2022, with a 5-year trough of $16.4 million in Q2 2023.
  • For the 4-year period, TriSalus Life Sciences' Assets Average averaged around $66.4 million, with its median value being $27.7 million (2023).
  • Per our database at Business Quant, TriSalus Life Sciences' Assets Average plummeted by 9346.09% in 2023 and then surged by 5361.13% in 2024.
  • Over the past 4 years, TriSalus Life Sciences' Assets Average (Quarter) stood at $136.7 million in 2022, then crashed by 78.72% to $29.1 million in 2023, then fell by 11.53% to $25.7 million in 2024, then soared by 51.18% to $38.9 million in 2025.
  • Its last three reported values are $38.9 million in Q3 2025, $35.0 million for Q2 2025, and $26.3 million during Q1 2025.